FIASP Solution Kanada - Kifaransa - Health Canada

fiasp solution

novo nordisk canada inc - insuline asparte - solution - 100unité - insuline asparte 100unité - insulins

FIASP Solution Kanada - Kifaransa - Health Canada

fiasp solution

novo nordisk canada inc - insuline asparte - solution - 100unité - insuline asparte 100unité - insulins

Insulin aspart Sanofi Umoja wa Ulaya - Kifaransa - EMA (European Medicines Agency)

insulin aspart sanofi

sanofi winthrop industrie - insuline asparte - diabète sucré - les médicaments utilisés dans le diabète - insulin aspart sanofi is indicated for the treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.

Kirsty (previously Kixelle) Umoja wa Ulaya - Kifaransa - EMA (European Medicines Agency)

kirsty (previously kixelle)

biosimilar collaborations ireland limited - insuline asparte - diabète sucré - les médicaments utilisés dans le diabète - kirsty is indicated for treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.

Fiasp ultra-fast-acting FlexTouch Solution injectable Uswisi - Kifaransa - Swissmedic (Swiss Agency for Therapeutic Products)

fiasp ultra-fast-acting flextouch solution injectable

novo nordisk pharma ag - insulinum aspartum - solution injectable - insulinum aspartum 600 nmol corresp. insulinum aspartum 100 u., glycerolum, zincum ut zinci acetas dihydricus, dinatrii phosphas dihydricus, arginini hydrochloridum, nicotinamidum, conserv.: phenolum 1.5 mg, metacresolum 1.72 mg, aqua ad iniectabile, q.s. ad solutionem pro 1 ml. - le diabète sucré - biotechnologika

Fiasp ultra-fast-acting Penfill Solution injectable Uswisi - Kifaransa - Swissmedic (Swiss Agency for Therapeutic Products)

fiasp ultra-fast-acting penfill solution injectable

novo nordisk pharma ag - insulinum aspartum - solution injectable - insulinum aspartum 600 nmol corresp. insulinum aspartum 100 u., glycerolum, zincum ut zinci acetas dihydricus, dinatrii phosphas dihydricus, arginini hydrochloridum, nicotinamidum, conserv.: phenolum 1.5 mg, metacresolum 1.72 mg, aqua ad iniectabile, q.s. ad solutionem pro 1 ml. - le diabète sucré - biotechnologika

Fiasp ultra-fast-acting Solution injectable Uswisi - Kifaransa - Swissmedic (Swiss Agency for Therapeutic Products)

fiasp ultra-fast-acting solution injectable

novo nordisk pharma ag - insulinum aspartum - solution injectable - insulinum aspartum 600 nmol corresp. insulinum aspartum 100 u., glycerolum, zincum ut zinci acetas dihydricus, dinatrii phosphas dihydricus, arginini hydrochloridum, nicotinamidum, conserv.: phenolum 1.5 mg, metacresolum 1.72 mg, aqua ad iniectabile, q.s. ad solutionem pro 1 ml. - le diabète sucré - biotechnologika

Fiasp 100 E/ml ultra-fast-acting PumpCart Solution injectable en Cartouche Uswisi - Kifaransa - Swissmedic (Swiss Agency for Therapeutic Products)

fiasp 100 e/ml ultra-fast-acting pumpcart solution injectable en cartouche

novo nordisk pharma ag - insulinum aspartum - solution injectable en cartouche - insulinum aspartum 6.15 mg corresp. insulinum aspartum 100 u., phenolum, metacresolum, glycerolum, zincum ut zinci acetas dihydricus, dinatrii phosphas dihydricus, arginini hydrochloridum, nicotinamidum, acidum hydrochloridum q.s. ad ph, natrii hydroxidum q.s. ad ph, aqua ad iniectabile, q.s. ad solutionem pro 1 ml corresp. natrium 6.15 mg. - le diabète sucré - biotechnologika

CEFTIN - TAB 250MG Comprimé Kanada - Kifaransa - Health Canada

ceftin - tab 250mg comprimé

glaxosmithkline inc - céfuroxime (céfuroxime axétil) - comprimé - 250mg - céfuroxime (céfuroxime axétil) 250mg - second generation cephalosporins

CEFTIN - TAB 500MG Comprimé Kanada - Kifaransa - Health Canada

ceftin - tab 500mg comprimé

glaxosmithkline inc - céfuroxime (céfuroxime axétil) - comprimé - 500mg - céfuroxime (céfuroxime axétil) 500mg - second generation cephalosporins